Morningstar22d
Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology
PORTSMOUTH, N.H., Jan. 17, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with ...
Yahoo Finance22d
Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology
has reached a significant milestone with its Optilume ® Drug-Coated Balloon (DCB). The groundbreaking treatment for recurrent bulbar urethral strictures has had its five-year follow-up data from ...
Yahoo Finance22d
Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology
PORTSMOUTH, N.H., Jan. 17, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its ...
Mena FN22d
Optilume Drug-Coated Balloon Shows Long-Term Efficacy For Urethral Strictures: Five-Year Data Published In The Journal Of Urology
Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its Optilume® Drug-Coated Balloon (DCB).
urologytimes19d
ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures
The 30F balloon group showed higher functional success and greater improvements in Qmax and PVR compared to the 24F group. Functional success was achieved in 58% of patients at 5-year follow-up.